Evaluation of the immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Shan 4) with EasyFourTM in Indian infants administered per EPI schedule: A phase III trial
Dhingra, Mandeep S, Rao, Raman, Bhat, Swarnarekha, Joshi, Rajan, Kalra, Veena, Parikh, Harish R., Rao, S. Narasimha, Sethi, G. R., Shah, Nitin, Muzaffaruddin, M
Published in Human vaccines (01.07.2010)
Published in Human vaccines (01.07.2010)
Get full text
Journal Article
Evaluation of the immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Shan 4) with Easyfour™ in Indian infants administered per EPI schedule: A phase III trial
Dhingra, Mandeep S, Rao, Raman, Bhat, Swarnarekha, Joshi, Rajan, Kalra, Veena, Parikh, Harish R, Rao, S. Narasimha, Sethi, G.R., Shah, Nitin, Muzaffaruddin, M
Published in Human vaccines (01.07.2010)
Published in Human vaccines (01.07.2010)
Get full text
Journal Article